NOTICES OF INTENDED REGULATORY ACTION
Vol. 36 Iss. 10 - January 06, 2020

TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
Regulations for Prescriptive Authority for Nurse Practitioners
Notice of Intended Regulatory Action

Notice is hereby given in accordance with § 2.2-4007.01 of the Code of Virginia that the Board of Nursing intends to consider amending 18VAC90-40, Regulations for Prescriptive Authority for Nurse Practitioners. The purpose of the proposed action is to add a section to 18VAC90-40 to (i) include in regulation the statutory requirement that takes effect on July 1, 2020, that a prescription for a controlled substance that contains an opioid must be issued as an electronic prescription and (ii) provide for a one-year waiver from the requirement if a practitioner can demonstrate economic hardship or technological limitations beyond the practitioner's control or for other exceptional circumstances.

The agency intends to hold a public hearing on the proposed action after publication in the Virginia Register.

Statutory Authority: §§ 54.1-2400 and 54.1-3408.02 of the Code of Virginia.

Public Comment Deadline: February 5, 2020.

Agency Contact: Jay P. Douglas, R.N., Executive Director, Board of Nursing, 9960 Mayland Drive, Suite 300, Richmond, VA 23233-1463, telephone (804) 367-4520, FAX (804) 527-4455, or email jay.douglas@dhp.virginia.gov.

VA.R. Doc. No. R20-6115; Filed December 23, 2019, 3:38 p.m.
TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
Regulations Governing Pharmaceutical Processors
Notice of Intended Regulatory Action

Notice is hereby given in accordance with § 2.2-4007.01 of the Code of Virginia that the Board of Pharmacy intends to consider amending 18VAC110-60, Regulations Governing Pharmaceutical Processors. The purpose of the proposed action is to adopt the requirements of Chapter 690 of the 2019 Acts of Assembly regarding (i) registration of agents for patients certified to receive cannabidiol oil or THC-A oil; (ii) who may be employed to cultivate and extract chemicals from Cannabis plants; and (iii) wholesale distribution of oils between processors.

The agency intends to hold a public hearing on the proposed action after publication in the Virginia Register.

Statutory Authority: §§ 54.1-3442.6 and 54.1-3447 of the Code of Virginia.

Public Comment Deadline: February 5, 2020.

 

Agency Contact: Caroline Juran, RPh, Executive Director, Board of Pharmacy, 9960 Mayland Drive, Suite 300, Richmond, VA 23233, telephone (804) 367-4456, FAX (804) 527-4472, or email caroline.juran@dhp.virginia.gov.

VA.R. Doc. No. R20-6129; Filed December 20, 2019, 1:22 p.m.